Identification | Back Directory | [Name]
L-Lysine, L-phenylalanyl-L-threonyl-L-isoleucyl-L-seryl-L-alanyl-L-α-aspartyl-L-threonyl-L-seryl- | [CAS]
1431957-73-1 | [Synonyms]
FTISADTSK L-Lysine, L-phenylalanyl-L-threonyl-L-isoleucyl-L-seryl-L-alanyl-L-α-aspartyl-L-threonyl-L-seryl- | [Molecular Formula]
C42H68N10O16 | [MOL File]
1431957-73-1.mol | [Molecular Weight]
969.06 |
Hazard Information | Back Directory | [Uses]
FTISADTSK is an endogenous stable signature peptide from Trastuzumab monitored by selected reaction monitoring (SRM)[1]. | [References]
[1] Bults P, et al. LC-MS/MS-Based Monitoring of In Vivo Protein Biotransformation: Quantitative Determination of Trastuzumab and Its Deamidation Products in Human Plasma. Anal Chem. 2016;88(3):1871-1877. DOI:10.1021/acs.analchem.5b04276 |
|
Company Name: |
MedChemExpress
|
Tel: |
021-58955995 |
Website: |
www.medchemexpress.com |
|